88 related articles for article (PubMed ID: 3319686)
1. [Interaction of drugs with alpha 1-acid glycoprotein (orosomucoid)].
Bender KI; Lutsevich AN
Farmakol Toksikol; 1987; 50(5):110-9. PubMed ID: 3319686
[No Abstract] [Full Text] [Related]
2. Drug binding sites on human alpha-1-acid glycoprotein.
Müller WE
Prog Clin Biol Res; 1989; 300():363-78. PubMed ID: 2674971
[No Abstract] [Full Text] [Related]
3. Drug binding to human alpha-1-acid glycoprotein in health and disease.
Kremer JM; Wilting J; Janssen LH
Pharmacol Rev; 1988 Mar; 40(1):1-47. PubMed ID: 3064105
[No Abstract] [Full Text] [Related]
4. Blood binding and tissue transfer of drugs: the influence of alpha 1 acid glycoprotein binding.
Belaiba R; Riant P; Urien S; Brée F; Albengres E; Barré J; Tillement JP
Prog Clin Biol Res; 1989; 300():287-305. PubMed ID: 2674966
[No Abstract] [Full Text] [Related]
5. Contribution of the variants of alpha 1-acid glycoprotein to its binding of drugs.
Baumann P; Eap CB
Prog Clin Biol Res; 1989; 300():379-97. PubMed ID: 2674972
[No Abstract] [Full Text] [Related]
6. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding.
Østergaard J; Heegaard NH
Electrophoresis; 2003 Sep; 24(17):2903-13. PubMed ID: 12973793
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic consequences of altered binding of drugs to alpha 1-acid glycoprotein.
Belpaire FM; Bogaert MG
Prog Clin Biol Res; 1989; 300():337-50. PubMed ID: 2674969
[No Abstract] [Full Text] [Related]
8. Drug binding to alpha 1-acid glycoprotein studied by circular dichroism.
Otagiri M; Yamamichi R; Maruyama T; Imai T; Suenaga A; Imamura Y; Kimachi K
Pharm Res; 1989 Feb; 6(2):156-9. PubMed ID: 2762215
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the interaction between alpha-1-acid glycoprotein and tamoxifen and its metabolites.
Paterson SC; Lim CK; Smith KD
Biomed Chromatogr; 2003; 17(2-3):143-8. PubMed ID: 12717803
[TBL] [Abstract][Full Text] [Related]
10. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
Tillement JP; Duché JC; Barré J
Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
[TBL] [Abstract][Full Text] [Related]
11. Binding site for basic drugs on alpha 1-acid glycoprotein as revealed by chemometric analysis of biochromatographic data.
Kaliszan R; Nasal A; Turowski M
Biomed Chromatogr; 1995; 9(5):211-5. PubMed ID: 8593420
[TBL] [Abstract][Full Text] [Related]
12. [Binding of perazine metabolites and phenothiazine derivatives to acid alpha 1-glycoprotein].
Schley J
Arzneimittelforschung; 1983; 33(2):185-7. PubMed ID: 6133521
[No Abstract] [Full Text] [Related]
13. Elementary pharmacokinetics in clinical practice. 6: Drug concentration monitoring.
Paxton JW
N Z Med J; 1982 Mar; 95(703):150-3. PubMed ID: 6952127
[No Abstract] [Full Text] [Related]
14. Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.
Pike E; Kierulf P; Skuterud B; Bredesen JE; Lunde PK
Br J Clin Pharmacol; 1983 Sep; 16(3):233-9. PubMed ID: 6626414
[TBL] [Abstract][Full Text] [Related]
15. Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.
Bree F; Houin G; Barre J; Riant P; Tillement JP
Prog Clin Biol Res; 1989; 300():321-36. PubMed ID: 2674968
[No Abstract] [Full Text] [Related]
16. Comparison of drug binding capacities of three AAG glycan variants of human origin.
Bree F; Rouzeau JD; Durand G; Gardier A; Tillement JP
Prog Clin Biol Res; 1989; 300():405-8. PubMed ID: 2506553
[No Abstract] [Full Text] [Related]
17. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
Belpaire FM; Chindavijak B; Bogaert MG
J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
[TBL] [Abstract][Full Text] [Related]
18. Binding of drugs with a quaternary ammonium group to alpha-1 acid glycoprotein and asialo alpha-1 acid glycoprotein.
van der Sluijs P; Meijer DK
J Pharmacol Exp Ther; 1985 Sep; 234(3):703-7. PubMed ID: 4032288
[TBL] [Abstract][Full Text] [Related]
19. Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: implications for chronopharmacology.
Bruguerolle B; Arnaud C; Levi F; Focan C; Touitou Y; Bouvenot G
Prog Clin Biol Res; 1989; 300():199-214. PubMed ID: 2674964
[No Abstract] [Full Text] [Related]
20. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
Alván G
Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
[No Abstract] [Full Text] [Related]
[Next] [New Search]
